Akèy › Kansè Poumon ki pa ti selil › Wisconsin

Etid klinik pou Kansè Poumon ki pa ti selil nan Wisconsin

45 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan Wisconsin.

Vil nan Wisconsin

Tèks ofisyèl etid la (Anglè)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
ak 52 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Essentia Health-Hayward Clinic, Hayward
ak 2 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07293247

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

Ap rekriteFaz 1/2

Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0135, Madison

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07680764

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #33, Milwaukee

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Bellin Memorial Hospital, Green Bay
Froedtert Menomonee Falls Hospital, Menomonee Falls
ProHealth D N Greenwald Center, Mukwonago
ak 3 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07388524

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Wisconsin Institute for Medical Research, Madison

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
ak 18 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

HSHS St. Vincent Hospital Regional Cancer Center, Green Bay
Local Institution - 0421, Marshfield

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07361510

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Milwaukee

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05877599

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Minnesota Oncology Hematology, P.A., Hudson
Froedtert Hospital/Medical College of Wisconsin, Milwaukee

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Mercyhealth, Janesville

Ap rekriteFaz 3

Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT05920356

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Milwaukee

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Aurora Cancer Care-Grafton, Grafton
Aurora BayCare Medical Center, Green Bay
Aurora St. Luke's Medical Center, Milwaukee

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06758401

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Schofield

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06868277

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

University Hospital and UW Health Clinics, Madison
Medical College of Wisconsin, Milwaukee

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06890598

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Clinic-Chippewa Center, Chippewa Falls
Aurora Saint Luke's South Shore, Cudahy
ak 27 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03191149

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Appleton

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06357533

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Gundersen Lutheran Medical Center, La Crosse

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06712316

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

UW Health Carbone Cancer Center, Madison

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676

A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)

Medical College of Wisconsin, Milwaukee

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06855771

HEARTS Trial for Thoracic Cancers

University of Wisconsin - Madison, Madison

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07132918

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ThedaCare Regional Cancer Center, Appleton

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Froedtert Hospital - Clinical Cancer Center, Milwaukee

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06914128

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Ascension Network - St Elizabeth's Hospital, Appleton
Ascension Columbia St. Mary's, Milwaukee

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06793215

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Circuit Clinical/SSM Health Dean Medical Group ( Site 0129), Madison

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06345729

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Medical College of Wisconsin, Milwaukee

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06561685

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Eau Claire

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07291037

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

The Board of Regents of the University of Wisconsin, Madison

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07070232

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Research Site, Milwaukee

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06350097

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

University of Wisconsin - Carbone Cancer Center, Madison

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06586515

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

University of Wisconsin- Madison, Madison

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Northwest Wisconsin Cancer Center, Ashland

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06686771

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Wisconsin (Carbone Cancer Center), Madison

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06026410

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Langlade Hospital and Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
ak 27 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Aurora Saint Luke's South Shore, Cudahy
ak 18 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
Gundersen Lutheran Medical Center, La Crosse
ak 5 plis

Ap rekriteFaz 2

18 Minutes · Tout sèks · Mizajou May 5, 2026 · NCT06031688

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Univeristy of Wisconsin, Madison

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04317534

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Aurora Saint Luke's South Shore, Cudahy
ak 26 plis

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06616584

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.